• Blog
  • Fetal Bovine Serum Market Growth Analysis | 2022-2028

    Fetal Bovine Serum Market Growth Analysis | 2022-2028

    Fetal Bovine Serum Market Growth Analysis | 2022-2028
    Report code - SR2274 Delivery - 2 Weeks
    Fetal Bovine Serum Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth O See more...

    Market Insights

    The Fetal Bovine Serum Market was estimated at US$ 874.1 million in 2021 and is expected to grow at a CAGR of 5.18% during 2022-2028 to reach US$ ~1190 million in 2028.

    Wish to get a free sample? Register Here

    What is fetal bovine serum?

    Fetal Cow Serum (FBS) is obtained from the blood of a bovine foetus using a closed collecting system, which is usually done at a slaughterhouse. In cell culture, the serum is typically utilized as a supplement to the basal growth media. Because of its high concentration of embryonic development hormones, fetal bovine serum (FBS) is the most commonly used form of serum. In cell culture, the serum provides a wide range of benefits, including low molecular weight nutrients, macromolecular proteins, carrier proteins of water-insoluble components, and other substances required for cell growth in vitro, such as hormones and attachment factors.

    Fetal bovine serum is a form of byproduct that is created in the meat processing industry. Several well-known applications, particularly in the pharmaceutical and biotechnology research industries, are used in the procedures. It is known that fetal bovine serum can be obtained from the entire blood of normal bovine fetuses. It is widely utilized in a variety of applications, including various diagnostic systems and research projects.

    Market Dynamics

    The increasing need for fetal bovine serum for research and development projects across a variety of areas, particularly in the pharmaceutical and drug development arena, is one of the primary market drivers responsible for the growth of the fetal bovine serum market.

    In addition, the rising frequency of acute and chronic diseases worldwide, as well as the efficacy of fetal bovine serum, are likely to drive fetal bovine serum adoption, hence fueling the growth of the global fetal bovine serum market during the forecast period. The growing ethical concerns associated with the collection of fetal bovine serum are likely to stifle the expansion of the worldwide fetal bovine serum market.

    The global fetal bovine serum market is being driven by reasons such as a rapid increase in culture media consumption in emerging countries around the world, which is a key driver driving the market's growth and demand. Furthermore, an increase in R&D activities aimed at the launch of novel biopharmaceuticals as well as the expansion of the biopharmaceutical industry are expected to boost market growth.

    Furthermore, an increase in research investments and financing in both developed and emerging countries supports market expansion.

    However, ethical and scientific concerns about the potential misuse of biotechnology research procedures, as well as a scarcity of competent employees, limit the market for fetal bovine serum. Furthermore, the accessibility of alternatives such as chemically defined media, serum-free media, and others impedes market growth. Furthermore, the fetal bovine serum market is undergoing a paradigm shift as a result of considerable increases in FBS prices in recent years, which operate as a fundamental restraint. This price increase is due to a huge increase in demand for FBS while a decrease in production. On the contrary, the untapped potential of emerging markets is expected to present attractive chances to key players in the fetal bovine serum market in the near future. Other issues that may limit market expansion include volatile fetal bovine serum prices and disparities between the various geographical segments from which the serum is supplied and collected.

    The overall impact of COVID-19 on the fetal bovine serum market remains good. Fetal bovine serum is widely utilized in cell culture preparation and vaccine manufacturing. In vitro, testing of vaccines and antivirals typically necessitates the use of culture media in which the targeted virus or bacteria is cultivated and the response is identified. Fetal bovine serum is utilized as a supplement in vaccine-growing media. For example, Viral Transport Media is commonly constituted of Fetal Bovine Serum, according to a study publication titled 'Role of Viral Transport Media in Sustaining COVID-19 Testing' released in October 2020. (FBS). For storing and transporting samples, a viral transport medium is utilized. A viral transport media (VTM) is favored over other varieties because it is a non-toxic blend of antimicrobials and buffered solutions capable of preserving the COVID-19 virus while removing contaminating flora that could interfere with testing. Fetal bovine serum-based VTM has been shown to be compatible with a wide range of clinical procedures, including PCR, direct antigen testing, and culture, allowing many assays to be conducted from the same sample. As a result, the fetal bovine serum market is predicted to expand rapidly.

    Fetal Bovine Serum Market Report Overview

    Market Size in 2028

    US$ ~1190 million

    Market Size in 2021

    US$ 874.1 million

    Market Growth (2022-2028)

    5.18% CAGR

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2028

     

    Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:

    • According to research published by the National Center for Biotechnology Information (NCBI), fetal bovine serum costs have grown by more than 300% due to increased demand and restricted availability. Nucleus Biologics developed its first premium cell culture solution in January 2017 to enable scientific advancements in research and development.

    Segments Analysis

    By Application Type

    The market is further segmented into drugs discovery, in-vitro fertilization, vaccine production, cell-based research, diagnostics, and biopharmaceutical manufacturing, among others.

    By End-User Type

    The market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CRO), academic and research organizations, and others. The biotechnology and pharmaceutical industries segment contributed the most revenue by end-user and is expected to rise significantly throughout the projection period due to the growing usage of FBS for biopharmaceuticals and human and animal vaccine manufacturing. Furthermore, an increase in demand from conventional serum consumers, as well as developments in research and academic endeavors by the commercial and public sectors, are important factors driving market expansion.

    Regional Analysis

    North America and Europe are currently the two major markets for fetal bovine serum, and they are likely to account for a higher share of the market during the forecast period. This is because these regions have large populations of bovine and cattle to permit the production of fetal bovine serum, as well as a high share of R&D activities. Because of its vast cattle population and favorable government backing for research and development, Australia is likely to present the largest market opportunity in the Asia Pacific.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The market for fetal bovine serum is highly competitive. The state of the economy and government assistance have a direct impact on the expansion of businesses. Based on their product's quality and market penetration in both the target and growing markets, these companies distinguish their fetal bovine serum driver in the industry. Furthermore, recent important mergers and acquisitions in the sector have had a big impact on the dynamics of competition. For instance:

    • In July 2017, GE Healthcare and Oritain revealed the debut of a serum fraud testing service.
    • Nucleus Biologics introduced the first premium fetal bovine serum in January 2017 to enable scientific advances while R&D projects are underway.

    The overall competitive landscape has been affected due to the key strategic activitiesThe following are the major players in the fetal bovine serum market:

    • HiMedia Laboratories
    • Merck KGaA
    • Bovogen Biologicals Pty Ltd
    • Atlanta Biologicals Inc.
    • TCS Biosciences Ltd
    • Tissue Culture Biologicals
    • Rocky Mountain Biologicals
    • GE Healthcare
    • Thermo Fisher Scientific
    • Bio-Techne
    • PAN-Biotech
    • Access Biologicals

    Research Methodology

    This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s fetal bovine serum market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Fetal Bovine Serum Market

    How lucrative is the future?

    Market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The fetal bovine serum market is expected to grow at a CAGR of 5.18% during 2022-2028.

    The fetal bovine serum market is estimated to grow from US$ 874.1 million in 2021 to US$ ~1.19 billion in 2028.

    The increasing need for fetal bovine serum for research and development projects across a variety of areas, particularly in the pharmaceutical and drug development arena, is one of the primary market drivers responsible for the growth of the fetal bovine serum market.

    North America and Europe are currently the two major markets for fetal bovine serum, and they are likely to account for a higher share of the market during the forecast period.

    The major players in the fetal bovine serum market are HiMedia Laboratories, Merck KGaA, Bovogen Biologicals Pty Ltd., Atlanta Biologicals Inc., TCS Biosciences Ltd., Tissue Culture Biologicals, Rocky Mountain Biologicals, GE Healthcare, Thermo Fisher Scientific, Bio-Techne, PAN-Biotech, Access Biologicals.

    The market is studied from 2016-2028.